%0
Generic
%T
CA15-3/MUC1 in CCTG MA-32 (NCT01101438): A phase III RCT of the effect of metformin vs. placebo on invasive disease free and overall survival in early stage breast cancer (BC).
%A Dowling, Ryan JO
%A Parulekar, Wendy R.
%A Gelmon, Karen A.
%A Shepherd, Lois E.
%A Virk, Shakeel
%A Ennis, Marguerite
%A Mao, Fangya
%A Ligibel, Jennifer A.
%A Hershman, Dawn L.
%A Rastogi, Priya
%A Mayer, Ingrid A.
%A Hobday, Timothy J.
%A Lemieux, Julie
%A Thompson, Alastair Mark
%A Rabaglio-Poretti, Manuela
%A Whelan, Timothy Joseph
%A Stambolic, Vuk
%A Chen, Bingshu E.
%A Goodwin, Pamela Jean
%I American Society of Clinical Oncology (ASCO)
%@ 1527-7755
%@ 0732-183X
%K Cancer Research
%K Oncology
%D 2018
%C American Society of Clinical Oncology (ASCO)
%U http://slubdd.de/katalog?TN_libero_mab2